EUDA Health Holdings ROE 2022-2025 | EUDA

Current and historical return on equity (ROE) values for EUDA Health Holdings (EUDA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
EUDA Health Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.113B $0.004B
EUDA Health Limited is a health technology company which operates southeast Asian digital healthcare ecosystem. The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions and aftercare services. EUDA Health Limited, formerly known as 8i Acquisition 2 Corp., is based in Singapore.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.812B 58.34
Tempus AI (TEM) United States $11.803B 0.00
Doximity (DOCS) United States $9.361B 38.54
Hims & Hers Health (HIMS) United States $8.207B 66.76
IRhythm Technologies (IRTC) United States $5.429B 0.00
Hinge Health (HNGE) United States $3.287B 0.00
Privia Health (PRVA) United States $2.921B 182.69
Heartflow (HTFL) United States $2.635B 0.00
Inspire Medical Systems (INSP) United States $2.522B 41.72
10x Genomics (TXG) United States $2.035B 0.00
Enovis (ENOV) United States $1.765B 9.27
Omnicell (OMCL) United States $1.596B 32.62
Azenta (AZTA) United States $1.370B 59.76
Phreesia (PHR) United States $1.350B 0.00
Clover Health Investments (CLOV) United States $1.276B 0.00
Schrodinger (SDGR) United States $1.267B 0.00
Fulgent Genetics (FLGT) United States $0.915B 0.00
Claritev (CTEV) United States $0.730B 0.00
Talkspace (TALK) United States $0.535B 107.67
Veradigm (MDRX) United States $0.534B 0.00
Butterfly Network (BFLY) United States $0.523B 0.00
Evolent Health (EVH) United States $0.464B 0.00
Standard BioTools (LAB) United States $0.461B 0.00
Zepp Health (ZEPP) Netherlands $0.365B 0.00
Carlsmed (CARL) United States $0.338B 0.00
TruBridge (TBRG) United States $0.306B 14.08
SOPHiA GENETICS SA (SOPH) Switzerland $0.296B 0.00
CapsoVision (CV) United States $0.265B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.225B 0.00
KORU Medical Systems (KRMD) United States $0.202B 0.00
MDxHealth SA (MDXH) Belgium $0.188B 0.00
Nyxoah SA (NYXH) Belgium $0.181B 0.00
Health Catalyst (HCAT) United States $0.166B 0.00
CareCloud (CCLD) United States $0.135B 7.40
Outset Medical (OM) United States $0.089B 0.00
NetraMark Holdings (AINMF) Canada $0.076B 0.00
Pulmonx (LUNG) United States $0.066B 0.00
American Well (AMWL) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.050B 0.00
Evaxion - (EVAX) Denmark $0.036B 0.00
111 (YI) China $0.035B 0.00
Precipio (PRPO) United States $0.032B 0.00
Predictive Oncology (POAI) United States $0.027B 0.00
Lunai Bioworks (LNAI) United States $0.024B 0.00
Zhongchao (ZCMD) China $0.017B 0.00
Healthcare Triangle (HCTI) United States $0.013B 0.00
Bullfrog AI Holdings (BFRG) United States $0.010B 0.00
Movano (MOVE) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
PROFUSA (PFSA) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.002B 0.00
MSP Recovery (MSPR) United States $0.001B 0.00